The FDA is receiving funding for its operations via a bill, with Andy Harris involved.
4 reports, 4 independent
Updated Sep 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA is receiving funding for its operations via a bill, with Andy Harris involved.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Harris criticized the FDA shortage database and looked into Canadian medication options.1 source
The House bill provided FDA funding but also cut WIC benefits, influenced by Trump's budget request.1 source
Funding bill passed for FDA operations, involving Andy Harris.1 source
Keep exploring
The entities involved
- FDA
-
Andy Harris
U.S. Representative from Maryland
Nothing else this week.
Related events
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.
- FDA policy proposal affects the operations of AI, Inc.
- Expertise is guiding drug development toward regulatory approval, involving the FDA and David Rubenstein.
- Congress introduced AI legislation, CMS expanded value-based models, FDA built AI infrastructure, and FTC rescinded a health data breach policy.
- Adam Craig reported positive results that could support FDA approval for a treatment.